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Abstract The purpose of this study was to
compare electron beam computed tomography
(EBT) with transthoracic echocardiography
(TTE) in determining aortic valve area (AVA).
Thirty patients (9 females, 21 males) underwent
a contrast-enhanced EBT scan (e-Speed, GE,
San Francisco, CA, USA) and TTE within
17 ± 12 days. In end-inspiratory breath hold, a
prospectivelyecg-triggeredscanwasacquiredwith
a beam speed of 50–100 ms, a collimation of
2 · 1.5 mm and an increment of 3.0 mm. The
AVA was measured with planimetry. A complete
TTE study was performed in all patients, and
the AVA was computed using the continuity
equation. There was close correlation between
AVA measured with EBT and AVA assessed with
TTE (r = 0.60, P < 0.01). The AVA measured
with EBT was 0.51 ± 0.46 cm
2 larger than the
AVA calculated with TTE measurements. EBT
appeared to be a valuable non-invasive method to
measure the AVA. EBT measures the anatomical
AVA, while with TTE the functional AVA is
calculated, which explains the difference in results
between the methods.
Keywords Aortic valve stenosis  Electron beam
computed tomography  Echocardiography
Abbreviations
AVA Aortic valve area
AVC Aortic valve calciﬁcation
EBT Electron beam computed tomography
MRI Magnetic resonance imaging
TTE Transthoracic echocardiography
Introduction
Aortic valve sclerosis is common in the elderly
population, affecting about 25% of adults over
65 years of age [1, 2]. The presence of aortic
sclerosis, with or without demonstrable haemo-
dynamic obstruction, is associated with an
increase of approximately 50% in the risk of
cardiovascular death [3]. The timing of aortic
valve replacement surgery has also an effect on
mortality risk [4]. The indication for aortic valve
replacement generally is based on haemodynamic
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the presence of symptoms. Signiﬁcant reduction
in the aortic valve area (AVA) is also an
important indicator [4]. Hence, exact evaluation
of the aortic valve and the AVA is necessary to
make the best treatment decision.
Evaluation of aortic valve stenosis by means of
transthoracic echocardiography (TTE) has gained
widespread acceptance in clinical routine and
pressure gradients across the aortic valve have
shown to correlate well with invasive measure-
ments [5, 6]. Moreover, TTE is used to determine
the functional AVA, using the continuity equa-
tion [5, 6]. However, the reliability of TTE
measurements depends heavily on image quality,
which is inﬂuenced by aortic valve calciﬁcation
and adequacy of the ultrasound window [7–9].
The results also depend on the patient’s haemo-
globin level, heart rate and left ventricular func-
tion [7]. Thus, invasive conﬁrmation is often still
necessary preceding valve replacement surgery.
For this purpose, cardiac catheterization evaluat-
ing AVA by applying the Gorlin formula is
available [10]. However, this method may not
give reliable results, depending on cardiac func-
tion and aortic regurgitation [11]. Aforemen-
tioned techniques rely on and are affected by
physiological parameters. Moreover, catheteriza-
tion is an invasive procedure that may be asso-
ciated with serious complications [12]. Therefore,
new techniques are necessary to evaluate the
severity and progression of aortic sclerosis. These
new techniques could measure the anatomical
AVA, which measurement is independent of
physiological parameters.
Contrast-enhanced computed tomography is a
useful technique to evaluate cardiac structures,
like coronary arteries and aortic valves [13]. EBT,
a non-mechanical computed tomography scan
with a high temporal resolution (50–100 ms), is
widely used to assess cardiac calciﬁcation, which
is also an early marker of the aortic sclerotic
process [1, 2]. To assess cardiac calciﬁcation,
administration of contrast agent to the patient is
not necessary. Several studies have shown the
usefulness of assessing the degree of aortic valve
calciﬁcation (AVC) with EBT as a measure of the
severity of aortic valve sclerosis [14–17]. How-
ever, these studies did not use EBT to measure
the AVA. MacMillan et al. were the ﬁrst to use
contrast-enhanced EBT to measure the AVA
[18]. They were able to determine AVA in six
patients with known aortic sclerosis. We wished
to compare EBT and TTE in order to compare
the assessment of aortic stenosis with both meth-
ods. We hypothesize that EBT is an useful
method to evaluate aortic stenosis; both in terms
of AVA as well as AVC.
Methods
Between June 2004 and February 2006, patients
with a known peak gradient (‡ 30 mmHg) across
their native aortic valve were invited to partici-
pate in the study during their control visit to the
outpatient clinic of cardiology. All patients were
under control for valvular aortic stenosis. The
study was in accordance with principles that have
their origin in the Declaration of Helsinki, and
was approved by the local review board and all
patients gave their informed consent. All patients
were over 18 years of age, and had to be able to
lie ﬂat and hold their breath for 20 s. Patients
with congenital heart defects, renal insufﬁciency
(serum creatinin >120 lmol/l), known contrast
allergy or history of hyperthyroidism, thyroid
cancer, Kahlers disease, myasthenia gravis, pheo-
chromocytoma or mastocytosis were excluded.
Patients with a body weight over 100 kg were also
excluded because image quality of EBT is
impaired in obese patients.
Electron beam computed tomography
Scans were performed with an EBT scanner
(e-Speed, GE, San Francisco, CA, USA), in the
dual 1.5 mm slice mode with an image acquisition
time of 50 or 100 ms depending on patient size.
First, non-enhanced EBT data were collected
during end-inspiratory breath hold. The non-
enhanced scan was ecg-triggered at 42% of the
R–R interval. A set of 40 continuous axial coupes
were obtained from under the trachea bifurcation
to the heart. An Agatston calciﬁcation score of
the aortic valve was obtained [19]. Area and
volume of calciﬁcations were calculated and
summated. The localization and severity of
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to Bahler et al. [20].
Second, contrast-enhanced EBT data were
collected during end-inspiratory breath hold. To
achieve optimal contrast enhancement, bolus
time was determined for each patient individually
before EBT scanning. Bolus timing, using 20 ml
contrast agent, was done with the region of
interest placed in the ascending aorta. The ecg-
triggered multiphase scan was carried out with
120 ml contrast agent (Iomeron 400
 , Bracco,
Italy) followed by a saline bolus chaser. Contrast
and saline bolus chaser were injected through a
18G venﬂon, placed in a cubital vein, with a ﬂow
rate of 4 ml/s. Ecg-triggered multiphase scanning
started at 5% of the R–R interval, the ﬁrst phase,
and continued during systole till 50% of the R–R
interval, the last phase. Depending on the
patient’s heart rate and beam speed, measure-
ments were performed during 7 to 10 phases.
The data were transferred to a workstation
(GE Advanced Workstation, GE Medical,
Waukesha, WI, USA) and reviewed by 1 observer
(R D), blinded from echocardiographic results.
An axial view of the aorta valve was created with
a double oblique view. One oblique axis was put
trough the aortic valve in the coronal view of the
heart, see Fig. 1(A). The second oblique axis was
set in the created oblique view, see Fig. 1(B). The
AVA was than measured in six planes at several
levels in the created axial view of the aortic valve,
see Fig. 1(B). The plane with the smallest AVA
was selected and measured three times using
planimetry, see Fig. 1(C). The mean AVA was
assessed in this way for each phase. The phase
with the maximal mean AVA was selected and
was considered to be the AVA of concern. This
AVA was compared to TTE ﬁndings.
Transthoracic echocardiography
A complete TTE study was performed in all
patients by an experienced sonographer, blinded
for EBT, following a standard procedure
(GE Vingmed Ultrasound Vivid Five, GE Med-
ical Systems, Waukesha, WI). The diameter of the
left ventricular outﬂow tract was measured from
the parasternal long-axis view. Flow velocity in
the left ventricular outﬂow tract was assessed by
pulse-wave Doppler from the apical 4 chamber
approach. Flow velocity across the aortic valve
was measured in the apical 5 chamber view. The
AVA was computed using the continuity equa-
tion [5]. The presence of aortic regurgitation was
determined from standard images, and quantiﬁed
as the short-axis area of the regurgitant jet as a
percentage to the short-axis area of the left
ventricular outﬂow tract, moreover standard
images of the left ventricle were obtained to
evaluate left ventricular function and hypertro-
phy. Left ventricular function was based on
estimated ejection fraction and wall motion, and
was graded as being normal if the ejection
fraction ‡60%. Left ventricular dysfunction was
mild if the ejection fraction was 45–60%, moder-
ate if the ejection fraction 30–45%, or poor if the
Fig. 1 All patients underwent electron beam computed
tomography. (A) One oblique axis was put trough the
aortic valve in the coronal view of the heart. Based on this
orientation an oblique view was created. (B) The second
oblique axis was set in the created oblique view. Based on
this orientation an axial view of the aortic valve was made.
The aortic valve area (AVA) was than measured in six
planes at several levels in the created axial view of the
aortic valve. (C) The AVA was measured three times at
each level in each phase using planimetry. The mean AVA
was assessed for each phase. The phase with the maximal
mean AVA was selected and was considered to be the
AVA of concern
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123ejection fraction was <30%. To evaluate left
ventricular hypertrophy, posterior wall and septal
thickness were measured from the parasternal
length axis.
Statistical analysis
For the measurement of the AVA by EBT, 3
manual tracings made by 1 observer (R D) were
averaged. Results of continuous normally distrib-
uted variables are expressed as mean ± SD,
results of continuous not normally distributed
variables are expressed as median (range). The
data were analyzed with the use of standard
software (SPSS version 12.0.1, SPSS Institute,
Chicago, IL, USA) on a PC. The Spearman’s and
Pearson’s correlation coefﬁcients (r) were used to
establish the presence of linear relationships. To
compare not normally distributed data, the
Mann–Whitney U test was used. A Bland–Alt-
man analysis was used to evaluate the agreement
between the AVA assessed with EBT and TTE.
A level of signiﬁcance below 0,05 was deﬁned as
clinically signiﬁcant.
Results
A total of 61 patients were screened for partic-
ipation in the study. Nine females and 21 males
(age 70.9 ± 10.0 years) were enrolled in the study.
Eight patients were excluded because of renal
insufﬁciency, 1 because of known contrast allergy,
1 because of body weight over 100 kg, and 4
patients declined to undergo an EBT. Another 17
patients were excluded because the AVA could
not be assessed by TTE.
In the study group, the mean peak pressure
gradient across the valve was 64 ± 21 mmHg. Ten
patients had symptoms according to NYHA class
I, 12 patients class II and 8 patients class III. Left
ventricular end-diastolic diameter was
4.9 ± 0.6 cm, interventricular septal thickness
was 1.2 ± 0.3 cm and posterior wall thickness
was 1.1 ± 0.1 cm. Ninety percent of the patients
had signs of left ventricular hypertrophy on TTE.
Twenty two patients (73%) had normal left
ventricular function, 6 patients (20%) had mild
and 2 patients (7%) moderate left ventricular
dysfunction. Mild aortic regurgitation was present
in 8 patients (27%) and moderate aortic regurgi-
tation in 2 patients (7%). The average time
between TTE and EBT was 17 ± 12 days.
Aortic valve area
Mean AVA assessed with TTE was
0.99 ± 0.31 cm
2. The median AVA measured
with EBT was 1.34 (0.69–2.84) cm
2. There was a
signiﬁcant correlation between AVA measured
with EBT and AVA assessed with TTE (r = 0.60,
P < 0.01), as shown in Fig. 2. The AVA measured
with EBT was on average 0.51 ± 0.46 cm
2 larger
than the AVA assessed with TTE, which was
conﬁrmed with Bland–Altman analysis, see
Fig. 2. The difference in AVA between EBT
and TTE showed a not statistically signiﬁcant
trend to be larger in patients with mild aortic
regurgitation than without aortic regurgitation
(0.62 (0.23–1.22) cm
2 and 0.33 (–0.14–1.52) cm
2,
respectively, P = 0.08). The difference in AVA
did not differ between patients with normal left
ventricular function and left ventricular dysfunc-
tion (0.45 (–0.14–1.52) cm
2 and 0.43 (–0.03–1.26)
cm
2, respectively, P = 0.78)
Aortic valve calciﬁcation
The median Agatston score of the aortic valve
was 3363 (425–10230). There was a moderate, but
signiﬁcant, inverse correlation between the Agat-
ston score of the aortic valve measured with EBT
and AVA assessed with TTE (r = –0.38,
P = 0.04), as shown in Fig. 3. In 17 patients with
an AVA <1.0 cm
2 the aortic valve was more
calciﬁed than in 13 patients with an
AVA ‡ 1.0 cm
2 (Agatston score 3879 (1192–
10230) and 2447 (425–6378), respectively,
P = 0.04).
Discussion
EBT is an useful non-invasive method to evaluate
aortic stenosis, both in terms of AVA and AVC.
However, on average a larger AVA was mea-
sured with EBT than was assessed AVA with
TTE. Indeed, this is not surprising since EBT
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expected to be greater than the functional AVA
assessed with TTE. Because of calciﬁcations the
valvular leaﬂets are less ﬂexible, as a result the
AVA will be irregularly shaped, hence the AVA
becomes haemodynamically less efﬁcient. This
results in a discrepancy between the functional
and anatomical AVA.
Toour knowledge, the publication of MacMillan
etal. is the ﬁrststudy investigatingthe usefulness of
contrast-enhanced EBT to assess AVA [18]. In this
study, 8 patients with known calciﬁc aortic stenosis
underwent EBT one day after cardiac catheteriza-
tion.Insixoutofeightpatientscloseagreementwas
found, within a 0.25 cm
2 margin, between catheter-
ization-derived AVA and AVA measured with
EBT.In1patienttheAVAcouldnotbedetermined
EBT and in 1 patient the AVA was overestimated
by EBT with 0.60 cm
2.
The results of our study are in line with those
of MacMillan et al. Our study also showed that
EBT measures larger AVA compared to TTE.
The AVA is measured planimetrically with EBT,
so it can be considered as the anatomical AVA.
Our study as well as the study of MacMillan et al.
compared this anatomical AVA to the functional
AVA. This functional AVA is derived from
haemodynamic characteristics of the aortic valve,
(pressure changes and ﬂow velocity changes)
across the aortic valve. The functional AVA is
supposed to yield the haemodynamic relevant
AVA. However, using the continuity equation,
the AVA is assumed to be circular, which does
not reﬂect the actual morphology of the oriﬁce of
the stenotic valve, especially not in case of heavy
calciﬁcation.
TTE is the principal diagnostic tool in routine
clinical practice to assess the AVA, next to
Fig. 3 Aortic valve calciﬁcation can be quantiﬁed with
electron beam computed tomography using the Agatston
score. The Agatston score correlates well with the aortic
valve area (AVA) measured with transthoracic echocar-
diography (TTE)(r = –0.38, P = 0.04). – – – = 95% conﬁ-
dence interval
Fig. 2 By using electron beam computed tomography
(EBT) planimetry the aortic valve area (AVA) can be
measured. (A) AVA measured with EBT correlate well
with those assessed with transthoracic echocardiography
(TTE) (r = 0.60, P < 0.01). (B) AVA measured with EBT
is larger on average than AVA assessed with TTE, as is
conﬁrmed with Bland–Altman analysis, exhibiting a mean
difference of 0.51 ± 0.46 cm
2. – – – = 95% conﬁdence
interval
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123cardiac catheterization. To determine the AVA
with TTE, the continuity equation is used [5, 6],
which yields the functional AVA. However, this
technique has its limitations. First, TTE is not
suitable in every patient with aortic valve sclero-
sis. Poor sonographic windows and calciﬁed
deposits in the aortic valve and cardiac wall
hamper the determination of the left ventricular
outﬂow diameter. A small fault in the measure-
ment of this diameter can seriously inﬂuence the
calculated AVA, because this diameter is squared
in the continuity equation. Moreover, if the
ultrasound beam is not directed parallel to the
velocity jet, peak transvalvular velocity may be
underestimated. Hence the peak pressure gradi-
ent and AVA may be underestimated. Second,
additional cardiac dysfunction can inﬂuence the
outcome of TTE measurements. The ﬂow velocity
can be decreased in case of poor left ventricular
function, even though there is an anatomical
small AVA. This leads to an underestimation of
the severity of the aortic stenosis. Furthermore,
the severity of aortic stenosis can be overesti-
mated in cases with concomitant aortic regurgi-
tation. Consequently, the aortic valve stenosis is
overestimated [7–9]. Our study also showed a
larger difference in AVA between EBT and TTE
in patients with additional mild aortic regurgita-
tion EBT is not inﬂuenced by aortic regurgitation,
therefore EBT is a more reliable technique, in
those patients, to conclude about the severity of
aortic stenosis.
The larger AVA measured by EBT compared
to TTE and cardiac catheterization may be
related to slice orientation. In order to get an
axial view of the aortic valve, the image has to be
rotated in two planes by the observer. If the
selected axial view is not situated perpendicular
to the aortic valve, the AVA is overestimated.
Moreover, from this axial view the plane with the
smallest AVA has to be selected. Although the
temporal resolution of EBT is high, it is possible
that the smallest AVA is situated between 2
planes. Hence, the AVA can be overestimated.
Nevertheless, we addressed this problem by
acquiring several slices at different levels of the
aortic valve. This is necessary to minimize the
potential of AVA overestimation because of
imprecise localization.
In addition to the measurement of AVA, AVC
can be quantiﬁed with EBT. Many studies have
made clear that EBT is also effective in the
evaluation of AVC [14–17, 21, 22]. The ﬁndings of
these studies suggest that elevated AVC scores
are a marker for the presence of aortic stenosis;
our study underlined these ﬁndings. A diagnostic
threshold value of 1000 Agatson units has a
sensitivity of 93% to detect severe aortic stenosis
(AVA < 1.0 cm
2) according to Messika-Zeitoun
et al. [16]. Rosenhek et al. concluded that the
extent of AVC was a strong independent predic-
tor of outcome [23]. In a study population of 126
patients with asymptomatic severe aortic stenosis,
four-year event-free survival was 75% in patients
with mild AVC, compared to 20% in patients
with moderate or severe AVC.
As mentioned above, the grade of AVC is a
predictor of outcome in patients with aortic
stenosis. Although the echocardiographic severity
of aortic stenosis is correlated to AVC score, the
AVA can not be predicted from the AVC score.
So, to evaluate the severity of aortic valve stenosis
and to indicate whether aortic valve replacement
surgery is necessary it is inevitable to measure
AVA. In our study, we showed a signiﬁcant
correlation between the AVA measured with
EBT and the severity of aortic stenosis assessed
with TTE. However, further research is needed to
validate EBT as a technique to evaluate the
AVA.
Next to EBT, there are other non-invasive
imaging techniques being evaluated for their
value in AVA assessment. Alkadhi et al. com-
pared 16 detector row computed tomography to
tranesophageal echocardiography in the evalua-
tion of AVA in 20 patients with and 20 patients
without aortic stenosis [24]. They reported a
mean difference of 0.06 cm
2. Reant et al. per-
formed a similar study using magnetic resonance
imaging (MRI) [25]. They enrolled 39 patients
with aortic stenosis and compared the AVA
measured with MRI to tranesophageal echocar-
diography and cardiac angiography. Their results
suggest good correlation between techniques;
MRI and transesophageal echocardiography dif-
fered 0.01 cm
2, MRI and cardiac angiography
differed 0.06 cm
2. Both studies show that non-
invasive imaging techniques are a good possible
786 Int J Cardiovasc Imaging (2007) 23:781–788
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stenosis.
Conclusion
EBT appears to be valuable as a non-invasive
method to assess the severity of aortic valve
sclerosis. EBT holds the qualiﬁcations for accu-
rate assessment of the anatomy, morphology
and physiology of the aortic valve. However,
further investigations will have to be done to
verify whether EBT is a suitable non-invasive
imaging technique for evaluation of aortic valve
disease.
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